Arcus Biosciences, Inc. (RCUS)
24.57
-1.58
(-6.04%)
USD |
NYSE |
Sep 11, 16:00
24.57
0.00 (0.00%)
After-Hours: 16:29
Arcus Biosciences Gross Profit (TTM) : 108.00M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 108.00M |
| March 31, 2026 | 227.00M |
| December 31, 2025 | 237.00M |
| September 30, 2025 | 230.00M |
| June 30, 2025 | 252.00M |
| March 31, 2025 | 131.00M |
| December 31, 2024 | 248.00M |
| September 30, 2024 | 251.00M |
| June 30, 2024 | 234.00M |
| March 31, 2024 | 222.00M |
| December 31, 2023 | 101.00M |
| September 30, 2023 | 105.23M |
| June 30, 2023 | 106.20M |
| March 31, 2023 | 104.43M |
| December 31, 2022 | 98.00M |
| September 30, 2022 | 419.80M |
| June 30, 2022 | 389.83M |
| March 31, 2022 | 366.60M |
| Date | Value |
|---|---|
| December 31, 2021 | 352.03M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.484M |
| June 30, 2018 | 0.484M |
| March 31, 2018 | 0.484M |
| December 31, 2017 | 0.484M |
| September 30, 2017 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Halozyme Therapeutics, Inc. | 1.271B |
| AVITA Medical, Inc. | 61.68M |
| Iovance Biotherapeutics, Inc. | 120.66M |
| Editas Medicine, Inc. | 44.58M |
| Recursion Pharmaceuticals, Inc. | -48.49M |